By Josh White
Date: Tuesday 02 Jan 2024
LONDON (ShareCast) - (Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.
The AIM-traded firm said that as a result, investors would be issued 3,093,915 warrants, representing 40% of the drawdown's value divided by the reference price of 7.7572p.
It said the warrants would have an exercise price of 140% of the reference price, equating to 10.86p.
At 1336 GMT, shares in Genedrive were down 0.92% at 8.05p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
| Currency | UK Pounds |
| Share Price | 1.00p |
| Change Today | 0.100p |
| % Change | 11.11 % |
| 52 Week High | 2.50p |
| 52 Week Low | 0.23p |
| Volume | 8,236,420 |
| Shares Issued | 1,029.60m |
| Market Cap | £10.30m |
| RiskGrade | 747 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:29 | 285,714 @ 1.03p |
| 16:28 | 35,000 @ 0.96p |
| 16:23 | 258,000 @ 0.98p |
| 16:20 | 80,000 @ 0.98p |
| 16:15 | 217,983 @ 1.03p |
You are here: research